Ajmaline
Top View
- Proarrhythmogenic Effects of Lamotrigine During Ajmaline Testing for Brugada Syndrome
- ACC/AHA/ESC Guidelines for the Management of Patients with Supraventricular Arrhythmiasm — Executive Summary
- Important Information for Patients with Brugada Syndrome Or Brugada ECG Pattern 1
- Feasibility and Outcomes of Ajmaline Provocation Testing for Brugada Syndrome in Children in a Specialist Paediatric Inherited Cardiovascular Diseases Centre
- Role of Provocable Brugada ECG Pattern in the Correct Risk Stratification for Major Arrhythmic Events
- Effect of Ajmaline on Action Potential and Ionic Currents in Rat Ventricular Myocytes
- Ajmaline for the Diagnosis of Brugada Syndrome
- Ajmaline Challenge for the Diagnosis of Brugada Syndrome: Which Protocol?
- J Wave Syndromes As a Cause of Sudden Arrhythmic Death
- KV11.1, Nav1.5, and Cav1.2 Transporter Proteins As Antitarget for Drug Cardiotoxicity
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Guidelines on the Use of Ajmaline in Children for Diagnosis of Brugada Syndrome
- CAS Number Index
- Drug Repurposing Compound Library Plus (96-Well)
- CASE REPORT Cholestatic Hepatitis After Diagnostic Ajmaline Challenge
- Product Data Sheet
- Ajmaline in the Management of Cardiac Arrhythmias
- Prognostic Significance of the Sodium Channel Blocker Test in Patients with Brugada Syndrome